StonvexLoading…
StonvexStonvexStonvexCore line items from JBTM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2023 2023-09-30 |
|---|---|---|---|---|
Revenue | $3.80B | $1.72B | $1.66B | $403.60M |
Operating Income | $189.40M | $118.40M | $164.70M | Not available |
Net Income | $-50.50M | $85.40M | $582.60M | $441.60M |
EPS (Diluted) | $-0.98 | $2.65 | $18.13 | $13.73 |
Total Assets | $8.19B | $3.41B | $2.71B | Not available |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $167.90M | $1.23B | $483.30M | Not available |
Free Cash Flow OCF − CapEx | $238.10M | $194.70M | $19.10M | Not available |
Shares Outstanding | 52.00M | 31.84M | 31.79M | Not available |